FibroBiologics Inc. Commo... (FBLG)
FibroBiologics Common Stock Statistics
Share Statistics
FibroBiologics Common Stock has 37.74M shares outstanding. The number of shares has increased by 11.28% in one year.
| Shares Outstanding | 37.74M |
| Shares Change (YoY) | 11.28% |
| Shares Change (QoQ) | 5.05% |
| Owned by Institutions (%) | n/a |
| Shares Floating | 29.27M |
| Failed to Deliver (FTD) Shares | 704 |
| FTD / Avg. Volume | 0.24% |
Short Selling Information
The latest short interest is 2.5M, so 7.22% of the outstanding shares have been sold short.
| Short Interest | 2.5M |
| Short % of Shares Out | 7.22% |
| Short % of Float | 9.44% |
| Short Ratio (days to cover) | 18.27 |
Valuation Ratios
The PE ratio is -5.89 and the forward PE ratio is -6.12. FibroBiologics Common Stock's PEG ratio is 0.14.
| PE Ratio | -5.89 |
| Forward PE | -6.12 |
| PS Ratio | 0 |
| Forward PS | null |
| PB Ratio | 24.04 |
| P/FCF Ratio | -5.44 |
| PEG Ratio | 0.14 |
Enterprise Valuation
Currently the Enterprise Value (EV) is not available for FibroBiologics Common Stock.
| EV / Sales | n/a |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 1.12, with a Debt / Equity ratio of 3.86.
| Current Ratio | 1.12 |
| Quick Ratio | 1.12 |
| Debt / Equity | 3.86 |
| Debt / EBITDA | -0.77 |
| Debt / FCF | -0.87 |
| Interest Coverage | 686.85 |
Financial Efficiency
Return on Equity is n/a and Return on Invested Capital is n/a.
| Return on Equity | n/a |
| Return on Assets | n/a |
| Return on Invested Capital | n/a |
| Revenue Per Employee | $0 |
| Profits Per Employee | $-858.54K |
| Employee Count | 13 |
| Asset Turnover | 0 |
| Inventory Turnover | n/a |
Taxes
| Income Tax | 0 |
| Effective Tax Rate | 0% |
Stock Price Statistics
The stock price has increased by -92.84% in the last 52 weeks. The beta is 0.18, so FibroBiologics Common Stock's price volatility has been higher than the market average.
| Beta | 0.18 |
| 52-Week Price Change | -92.84% |
| 50-Day Moving Average | 1.18 |
| 200-Day Moving Average | 2.48 |
| Relative Strength Index (RSI) | 33.58 |
| Average Volume (20 Days) | 298.92K |
Income Statement
| Revenue | n/a |
| Gross Profit | 0 |
| Operating Income | -13.74M |
| Net Income | -11.16M |
| EBITDA | -13.74M |
| EBIT | -11.18M |
| Earnings Per Share (EPS) | -0.34 |
Balance Sheet
The company has 13.98M in cash and 10.55M in debt, giving a net cash position of 3.43M.
| Cash & Cash Equivalents | 13.98M |
| Total Debt | 10.55M |
| Net Cash | 3.43M |
| Retained Earnings | -35.52M |
| Total Assets | 16.45M |
| Working Capital | 1.5M |
Cash Flow
In the last 12 months, operating cash flow was -11.9M and capital expenditures -184K, giving a free cash flow of -12.09M.
| Operating Cash Flow | -11.9M |
| Capital Expenditures | -184K |
| Free Cash Flow | -12.09M |
| FCF Per Share | -0.37 |
Margins
| Gross Margin | n/a |
| Operating Margin | n/a |
| Pretax Margin | n/a |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
FBLG does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Payout Ratio | n/a |
| Earnings Yield | n/a |
| FCF Yield | n/a |
Analyst Forecast
The average price target for FBLG is $12, which is 1381.5% higher than the current price. The consensus rating is "Buy".
| Price Target | $12 |
| Price Target Difference | 1381.5% |
| Analyst Consensus | Buy |
| Analyst Count | 5 |
Scores
| Altman Z-Score | -3.78 |
| Piotroski F-Score | 1 |